Cure and SHIN enter this best-of-three group stage opener as two of the most consistent performers in the Korean scene, with Cure bringing veteran Terran macro discipline and strong late-game transitions while SHIN counters with aggressive Zerg swarm tactics and sharp early aggression. Recent form shows SHIN advancing from the prior season’s round of eight after key wins over ByuN, while Cure has maintained top-four finishes across multiple events despite occasional map losses to Zerg specialists. Head-to-head records favor neither decisively in current map pools, making map selection and opening adaptations pivotal. Both players carry fresh momentum from the ongoing league schedule with minimal travel or rest concerns, positioning the series as a high-skill test where small execution edges will decide advancement to group stage two.
Polymarketデータを参照したAI生成の実験的な要約。これは取引アドバイスではなく、このマーケットの解決方法には一切関係ありません。 · 更新日Cure – SHIN
シリーズライン
This market will resolve to "Cure" if Cure win the match against SHIN.
This market will resolve to "SHIN" if SHIN win the match against Cure.
If the match is canceled (not played at all), ends in a tie, or is delayed beyond 7 days from the scheduled date without a winner determined, this market will resolve to 50-50.
If the match begins but is not completed, and one team wins due to the opponent's forfeiture, disqualification, or walkover, this market will resolve to the team who wins.
If the match ends in a forfeit, disqualification, or walkover (team withdraws before the start and the other wins automatically), this market will resolve to 50-50.
The resolution source for this market will be official information from https://liquipedia.net/starcraft2/Main_Page. However, if https://liquipedia.net/starcraft2/Main_Page has not published final results within 2 hours after the event’s conclusion, a consensus of credible reporting may be used instead including video evidence.
In cases where a team’s listed name includes minor discrepancies from the resolution source, this market will resolve based on the underlying real-world match rather than exact name matching. Recognizable abbreviations, alternate or erroneous spellings, sponsor tags, affiliate or academy designations, regional identifiers, and minor formatting differences will be treated as referring to the same team, provided the intended team can be clearly and uniquely identified within the relevant competition. If a listed team name has no reasonable connection to any participating team, or if it matches or could reasonably refer to another team in the same competition such that the intended team cannot be unambiguously determined, this market will resolve 50-50.
マーケット開始日: May 20, 2026, 7:30 AM ET
Cure – SHIN
シリーズライン
This market will resolve to "Cure" if Cure win the match against SHIN.
This market will resolve to "SHIN" if SHIN win the match against Cure.
If the match is canceled (not played at all), ends in a tie, or is delayed beyond 7 days from the scheduled date without a winner determined, this market will resolve to 50-50.
If the match begins but is not completed, and one team wins due to the opponent's forfeiture, disqualification, or walkover, this market will resolve to the team who wins.
If the match ends in a forfeit, disqualification, or walkover (team withdraws before the start and the other wins automatically), this market will resolve to 50-50.
The resolution source for this market will be official information from https://liquipedia.net/starcraft2/Main_Page. However, if https://liquipedia.net/starcraft2/Main_Page has not published final results within 2 hours after the event’s conclusion, a consensus of credible reporting may be used instead including video evidence.
In cases where a team’s listed name includes minor discrepancies from the resolution source, this market will resolve based on the underlying real-world match rather than exact name matching. Recognizable abbreviations, alternate or erroneous spellings, sponsor tags, affiliate or academy designations, regional identifiers, and minor formatting differences will be treated as referring to the same team, provided the intended team can be clearly and uniquely identified within the relevant competition. If a listed team name has no reasonable connection to any participating team, or if it matches or could reasonably refer to another team in the same competition such that the intended team cannot be unambiguously determined, this market will resolve 50-50.
マーケット開始日: May 20, 2026, 7:30 AM ET
Cure and SHIN enter this best-of-three group stage opener as two of the most consistent performers in the Korean scene, with Cure bringing veteran Terran macro discipline and strong late-game transitions while SHIN counters with aggressive Zerg swarm tactics and sharp early aggression. Recent form shows SHIN advancing from the prior season’s round of eight after key wins over ByuN, while Cure has maintained top-four finishes across multiple events despite occasional map losses to Zerg specialists. Head-to-head records favor neither decisively in current map pools, making map selection and opening adaptations pivotal. Both players carry fresh momentum from the ongoing league schedule with minimal travel or rest concerns, positioning the series as a high-skill test where small execution edges will decide advancement to group stage two.
Polymarketデータを参照したAI生成の実験的な要約。これは取引アドバイスではなく、このマーケットの解決方法には一切関係ありません。 · 更新日
外部リンクに注意してください。
外部リンクに注意してください。
よくある質問